A humanized antibody with specificity for hepatitis B surface antigen

Human Antibodies

Volumn 7, Issue 3, 1996, Pages 113-122

  Jeih Ryu, Chun ^a   Padlan, Eduardo A ^b   Rae Jin, Byung ^a   Yoo, Ook Joon ^c   Hong, Hyo Jeong ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Antibody engineering; HBV neutralization; Humanized antibody; Prophylaxis

Indexed keywords

AMINO ACID; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ARTICLE; COMPLEMENTARITY DETERMINING REGION; ENGINEERING; HEPATITIS B; HUMAN; LIVER CELL; LIVER CELL CULTURE; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE; CHO CELLS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B SURFACE ANTIGENS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0030512979     PISSN: 10932607     EISSN: 1875869X     Source Type: Journal    
DOI: 10.3233/HAB-1996-7304     Document Type: Article

References (53)

1. Tiollais P, Buendia MA. Hepatitis B virus. Sci Am 1991; 264: 48
2. Beasley RP, Hung LY, Lee CY, Lan CC, Roan CH, Hung FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2: 1099
3. Todo S, Denetris AJ, Thiel DV, Teperman L, Fung JJ, Starzel TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619
4. Shawler DL, Bartholomew RM, Smith LM, Dilman RO. Human immune response to multiple injections of murine monoclonal IgG. J Immunol 1985; 135: 1530
5. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 1984; 81: 6851
6. LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response. Proc Natl Acad Sci USA 1989; 86: 4220
7. Khazaeli MB, Saleh MN, Liu TP, Meredith RF, Wheeler RH, Baker TS, King D, Secher D, Allen L, Rogers K, Colcher D, Schlom J, Shochat D, LoBuglio AF. Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 monoclonal antibody in humans. Cancer Res 1991; 51: 5461
8. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988; 332: 323
9. Queen C, Scheider WP, Selick HE, Payne PW, Landolfi NF, Duncan JF, Avdalvic NM, Levitt M, Junghans RP, Waldmann TA. A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci USA 1989; 86: 10029
10. Tempest PR, Bremner P, Lambert M, Taylor G, Furze JM, Carr FJ, Harris WJ. Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo. Bio/Technology 1991; 9: 266
11. Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 1992; 224: 487
12. Nakatani T, Lone YC, Yamakawa J, Kanaoka M, Gomi H, Wijdenes J, Noguchi H. Humanization of mouse anti-human IL-2 receptor antibody B-B10. Protein Eng 1994; 7: 435
13. Sato K, Tsuchiya M, Saldanha J, Koishihara Y, Ohsugi Y, Kishimoto T, Bendig MM. Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions. Mol Immunol 1994; 31: 371
14. Brown PS, Parenteau GL, Dirbas FM, Garsia RJ, Goldman CK, Bukowski MA, Junghans RP, Queen C, Hakimi J, Benjamin WR, Clark RE, Waldmann TA. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival. Proc Natl Acad Sci USA 1991; 88: 2663
15. Peterson DL, Nath N, Gavilanes F. Structure of hepatitis B surface antigen. J Biol Chem 1982; 257: 10414
16. Szmuness W, Stevens CE, Harly EJ, Hepatitis B vaccine in medical staff of haemodialysis units: Efficacy and subtype cross-protection. N Eng J Med 1982; 303: 1481
17. Ryu CJ, Jin BR, Chin HK, Han MH, Hong HJ, Cloning and Characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for the S antigen of hepatitis B virus. Gene 1994; 1244: 313
18. Guguen-Guillouzo C, Guillouzo A. Methods for preparation of adult and fetal hepatocytes. In: Guillouzo A, Guguen-Guillouzo C. eds, Isolated and Cultured Hepatocytes. Les editions INSERM Paris, Libbey, London, 1986
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 79: 4350.
20. Jin BR, Ryu CJ, Kang SK, Han MH, Hong HJ. Characterization of a murine-human chimeric antibody with specificity for the pre-S2 surface antigen of hepatitis B virus expressed in baculovirus-infected insect cells. Virus Res 1995; 38: 269
21. Subramani S, Mulligan R, Berg P. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acids in Simian virus 40 vectors. Mol Cell Biol 1981; 1: 854
22. Engvall E, Perlman P. Enzyme-linked immunosorbent assay, ELISA, III. Quantitation of specific antibodies by enzyme labeled anti-immunoglobulin in antigen coated tubes. J Immunol 1972; 109: 129
23. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. In: Current Protocols in Immunology, National Institute of Health. 1991.
24. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Meth 1985; 77: 305
25. Kim YS, Kang HS. Cloning and expression of hepatitis B virus surface antigen gene. Korean Biochem J 1984; 17: 70
26. Sells MA, Chen M-L, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987; 84: 1005
27. Gripon P, Diot C, Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: Effect of polyethylene glycol, on adsorption and penetration. Virology 1993; 192: 534
28. Hirt B. Selective extraction of polynoma DNA from infected mouse cell culturesJ Mol Biol 1967; 26: 365
29. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975; 98 503
30. Petit MA, Capel F, Riottot MM, Dauguet C, Pillot J. Antigenic mapping of the surface proteins of infectious hepatitis B virus particles. J Gen Virol mi; 68: 2759
31. Waters J, Pignatelli M, Galpin S, Ishihara K, Thomas HC. Virus-neutralizing antibodies to hepatitis B virus: The nature of an immunogenic epitope on the S gene peptide. J Gen Virol 1986; 67: 2467
32. Le Bouvier GH, Capper RH, Williams AE, Pelletier M, Katz AJ, Concurrently circulating hepatitis B surface antigen and hetero-tropic anti-HBs antibody. J Immunol 1976; 117: 2262
33. Peterson DL, Paul DA, Lam J, Tribby HE, Achord DT. Antigenic structure of hepatitis B surface antigen: Identification of " d" subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol 1984; 132: 920
34. Wands JR, Ben-Porath E, Wong EA. Monoclonal antibodies and hepatitis B: A new perspective using highly sensitive and specific radioimmunoassays. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease, New York: Grune and Stratton, 1984
35. Padlan EA. Anatomy of the antibody molecule. Mol Immunol 1994; 31: 169
36. Cook GP, Tomlinson IM, Walter G, Riethman H, Carter NP, Buluwela L, Winter G, Rabbitts TH. A map of the human immunoglobulin VH locus completed by analysis of the telomic region of chromosome 14q. Nature Genetics 1994; 7: 162
37. Cox JP, Tomlison IM, Winter G. A directory of human germline VK- segments reveals a strong bias in their usage. Eur J Immunol 1994; 24: 827
38. Dersimonian H, Schwartz RS, Barrett KJ, Stolla BD. Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. J Immunol 1987; 139: 2496
39. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest, 5th edn. Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH Publication No. 91-3242) 1991
40. Lorenz W. Schable KF, Thiebe R, Stavnezer J, Zachau HG. The Jk proximal region of the human K locus contains three uncommon WK genes which are arranged in opposite transcriptional polarities. Mol Immunol 1988; 25: 479
41. Schneider M, Hilschmann N. Die Primaerstruktur einer mono-klonaken Immunglobulin-L-kette der subgruppe IV vom K-Typ (Bence-Jones-Protein Len): einer neue Subgruppe der L-ketten vom /c-Type. Hoppe-Seyler’s Z Physiol Chem 1974; 355: 1164
42. Chothia C, Lesk AM, Tramontano A, Levitt M, Gill SJS, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ. Conformations of immunoglobulin hypervariable regions. Nature 1989; 342: 877
43. Carter P, Kelley RF, Rodrigues ML, Snedecor B, Covarrubias M, Velligan MD, Wong WLT, Rowland AM, Kotts CE, Carver ME, Yang M, Bourell JH, Shepard HM, Henner D. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Bio/Technology 1992; 10: 163
44. Chothia C, Novotny J, Bruccoleri R, Karplus M. Domain association in immunoglobulin: The packing of variable domains. J Mol Biol 1985; 186: 651
45. Padlan EA. A possible procedure for reducing the immunogenecity of antibody variable domains while preserving their ligand-binding properties. Mol Immunol 1991; 28: 489
46. Singer II, Kawka DW, DeMartino JA, Daughtery BL, Elliston KO, Alves K, Bush BL, Cameron PM, Cuba GC, Davies P, Forrest MJ, Kazazis DM, Law M-F, Lenny AB, Maclntyre DE, Meurer R, Padlan EA, Pandya S, Schmidt JA, Seamans TC, Scott S, Silberklang M, Willianmson AR, Mark GE. Optimal humanization of 1B4, and anti-CD 18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences. J Immunol 1993; 150: 2844
47. Ogata N, Ostberg L, Ehrlich PH, Wong DC, Miller RH, Purell RH. Marked prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a huirian monoclonal antibody to" the a determinant of hepatitis B surface antigen. Proc Natl Acad Sci USA 1993; 90: 3014
48. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Ostberg L. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757
49. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman A J, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus, Lancet 1990; 336: 325
50. Fujii HK, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakaki Y, Okochi K, Nakajima E. Gly15 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992; 184: 1152
51. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J. Hepatol 1991; 13: SI05
52. Okamato H, Yano K, Nozaki Y, Matsui A, Miyzaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992; 32: 264
53. Moriyama K, Nakajima E, Hohjoh H. Asayama R, Okochi K. Immunoselected hepatitis B virus mutant. Lancet 1991; 337: 125